The impact of SOX4‐activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma
ELECTROPHORESIS · 2024-08 · 45 (15-16) · 1408-1417
DOI: 10.1002/elps.202300255 ↗Kurz gefasst
Fachartikel in der Zeitschrift ELECTROPHORESIS, online erschienen am 17.04.2024. Verfasst von Cheng Ai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Bishan Hospital of Chongqing, Medical University, Chongqing, P. R. China. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, SOXC Transcription Factors, Adenocarcinoma of Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing CSTC.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is the predominant subtype within the spectrum of lung malignancies. CTHRC1 has a pro‐oncogenic role in various cancers. Here, we observed the upregulation of CTHRC1 in LUAD, but its role in cisplatin resistance in LUAD remains unclear. Bioinformatics analysis was employed to detect CTHRC1 and SRY‐related HMG‐box 4 (SOX4) expression in LUAD. Gene Set Enrichment Analysis predicted the enriched pathways related to CTHRC1. JASPAR and MotifMap databases predicted upstream transcription factors of CTHRC1. Pearson analysis was conducted to analyze the correlation between genes of interest. The interaction and binding relationship between CTHRC1 and SOX4 were validated through dual‐luciferase and chromatin immunoprecipitation assays. Quantitative real‐time polymerase chain reaction determined the expression of CTHRC1 and SOX4 genes. CCK‐8 was performed to assess cell viability and calculate IC 50 value. Flow cytometry examined the cell cycle. Comet assay and western blot assessed DNA damage. CTHRC1 and SOX4 were upregulated in LUAD. CTHRC1 exhibited higher expression in cisplatin‐resistant A549 cells compared to cisplatin‐sensitive A549 cells. Knockdown of CTHRC1 enhanced DNA damage during cisplatin treatment and increased the sensitivity of LUAD cells to cisplatin. Additionally, SOX4 modulated DNA damage repair (DDR) by activating CTHRC1 transcriptional activity, promoting cisplatin resistance in LUAD cells. SOX4 regulated DDR by activating CTHRC1, thereby enhancing cisplatin resistance in LUAD cells. The finding provides a novel approach to address clinical cisplatin resistance in LUAD, with CTHRC1 possibly serving as a candidate for targeted therapies in addressing cisplatin resistance within LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Bishan Hospital of Chongqing, Medical University, Chongqing, P. R. China.
- Department of Thoracic Surgery, Nanjing Drum Tower Hospital, The affiliated Hospital of Nanjing University Medical School, Nanjing, P. R. China.
- Lung Cancer Center, West China Hospital of Sichuan University, Chengdu, P. R. China.
ORCID-Profile: Wen Li
Förderung
- Natural Science Foundation of Chongqing CSTC
Zitieren
APA
Ai, C., Huang, Z., Rong, T., Shen, W., Yang, F., Li, Q., Bi, L., & Li, W. (2024). The impact of SOX4‐activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma. ELECTROPHORESIS, 45(15-16), 1408-1417. https://doi.org/10.1002/elps.202300255
Vancouver
Ai C, Huang Z, Rong T, Shen W, Yang F, Li Q, et al. The impact of SOX4‐activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma. ELECTROPHORESIS. 2024;45(15-16):1408-1417. doi:10.1002/elps.202300255
BibTeX
@article{Ai2024,
author = {Ai, Cheng and Huang, Zhenhao and Rong, Tenghao and Shen, Wang and Yang, Fuyu and Li, Qiang and Bi, Lei and Li, Wen},
title = {The impact of SOX4‐activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma},
journal = {ELECTROPHORESIS},
year = {2024},
volume = {45},
number = {15-16},
pages = {1408--1417},
doi = {10.1002/elps.202300255}
}
EUVIMED